AU Patent

AU2015258280B2 — Processes for preparing isoquinolinones and solid forms of isoquinolinones

Assigned to Infinity Pharmaceuticals Inc · Expires 2017-07-20 · 9y expired

What this patent protects

Abstract Polymorphs of chemical compounds that modulate kinase activity, including P13 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associates with kinase activity, including PI 3 kinase activity, are described h…

USPTO Abstract

Abstract Polymorphs of chemical compounds that modulate kinase activity, including P13 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associates with kinase activity, including PI 3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof. V) u 5000 10 20 30 40 Position [02 Theta] (Copper (Cu)) Polymorph Form A Fig. 1

Drugs covered by this patent

Patent Metadata

Patent number
AU2015258280B2
Jurisdiction
AU
Classification
—
Expires
2017-07-20
Drug substance claim
No
Drug product claim
No
Assignee
Infinity Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.